A detailed history of Frontier Wealth Management LLC transactions in Vbi Vaccines Inc stock. As of the latest transaction made, Frontier Wealth Management LLC holds 601,800 shares of VBIV stock, worth $427,278. This represents 0.01% of its overall portfolio holdings.

Number of Shares
601,800
Previous 601,800 -0.0%
Holding current value
$427,278
Previous $951,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$1.27 - $2.47 $718,566 - $1.4 Million
565,800 Added 1571.67%
601,800 $951,000
Q3 2021

Nov 12, 2021

SELL
$2.8 - $3.72 $1.68 Million - $2.23 Million
-600,000 Reduced 94.34%
36,000 $112,000
Q4 2020

Feb 16, 2021

BUY
$2.15 - $3.5 $77,400 - $126,000
36,000 Added 6.0%
636,000 $1.75 Million
Q2 2020

Aug 14, 2020

BUY
$0.87 - $3.13 $522,000 - $1.88 Million
600,000 New
600,000 $1.86 Million

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $183M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.